Pharmaceutical Executive Digest:
Having trouble viewing this e-mail? Click here.
Pharmaceutical Executive Europe  E-News
 
 
 
 
 
 

You can now follow us on Twitter at Twitter.com/pharmexecdigi
 
Survey
We asked 40 pharma leaders, do you think the pharma industry has achieved more transparency over the last few years?

Yes 46%
No 29%
It's the same as it's always been 25%

Talk to us:
jupton@advanstar.com

Advertise with us: mgoodrich@advanstar.com

26 June, 2012
In this Issue
The Pharma Top 20s
What were the Top 20 Global Pharma Products for 2011? What were the Top 20 Global Therapy Areas? The Top Corporations by US Prescriptions? Find out in our Pharma Top 20s slide show. Read more...
Putting the Real Emerging Market Lessons into Practice
The days when the emerging markets could be viewed as places to be colonized and exploited are long gone. Some big business companies have begun to understand that and pharma would do well to take a leaf out of their books, writes Nick Stephens. More...
Can Social Media Give Big Pharma Back its Reputation?
Industry's ability to master the external environment depends on making the 140-character shorthand of the Twitter generation its own. More...
Merck Serono Announces Restructuring Plan
Merck Serono has revealed its “final efficiency program” for operations in Switzerland, which includes confirmation of the closure of sites in Geneva and Coinsins and their associated job cuts. More...
Recruitment Profile

Council of Europe
Scientific Programme Officer - OMCL Quality Assurance Programme (Grade A1/A2)
Duty station: Strasbourg (France)
Ref No: e146/2012
Read more

 

Dassault Systèmes
Business Consultant Director
Life Sciences Director H/F
Dassault Systèmes, the 3D Experience Company, provides business and people with virtual universes to imagine sustainable innovations.
Read more

 

Council of Europe
Scientific Programme Officer - OMCL Quality Assurance Programme (Grade A1/A2)
Duty station: Strasbourg (France)
Ref No: e146/2012
Read more



Also in this issue…
Read the Latest Pharm Exec Global Digest
Latest Pharma Appointments
C-Suiters: Don't Look Down on Your Middle Managers